Ilana R Yurkiewicz, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Yurkiewicz’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A146955 · Current
Licensed to practise in California · since 2017 · expires 2027-01-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$15,925
Medicare paid this office $15,925 for 168 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 67 | $4,114 | $53 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 50 | $3,320 | $66 |
| Return visit (30+ min) | 34 | $3,148 | $70 |
| Short return visit (20+ min) | 31 | $2,471 | $59 |
| Short return visit (20+ min) | 19 | $1,004 | $46 |
See all 6 services
| Return visit (30+ min) | 67 | $4,114 | $53 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 50 | $3,320 | $66 |
| Return visit (30+ min) | 34 | $3,148 | $70 |
| Short return visit (20+ min) | 31 | $2,471 | $59 |
| Short return visit (20+ min) | 19 | $1,004 | $46 |
| Long return visit (40+ min) | 13 | $814 | $63 |
Who their Medicare patients are
168 Original Medicare patients in 2024. Average age 72 · Under 65 14% · 85 and older 9% · Women 68% · Also on Medicaid 21% · Health risk score 1.29. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 57% · Cancer 28% · Diabetes 22% · Coronary heart disease 20% · Depression 19% · Atrial fibrillation 16% · Chronic kidney disease 15% · Heart failure 12% · COPD 9% · Stroke 7%.
The office billed $115,909, Medicare allowed $24,372 and paid $15,925; for 269 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 168 | 269 | 72 | 1.29 | $115,909 | $15,925 |
| 2023 | 237 | 444 | 71 | 1.39 | $170,515 | $29,309 |
| 2022 | 217 | 367 | 72 | 1.23 | $152,627 | $33,108 |
| 2021 | 33 | 41 | 71 | 1.47 | $17,892 | $5,230 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 115 | $11,367 | $65 |
| Short return visit (20+ min) | 83 | $6,180 | $51 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 67 | $5,932 | $89 |
| Long return visit (40+ min) | 27 | $3,050 | $98 |
| Short return visit | 21 | $917 | $40 |
2022: 5 services
| Return visit (30+ min) | 97 | $9,550 | $75 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 49 | $7,064 | $144 |
| Long return visit (40+ min) | 58 | $6,647 | $102 |
| Short return visit (20+ min) | 59 | $3,779 | $57 |
| New patient visit (45+ min) | 14 | $1,809 | $129 |
2021: 1 service
| New patient visit (60+ min) | 15 | $2,644 | $176 |
Medicaid work
$1,040 in 2023
Medicaid paid $1,040 for 42 billed services this clinician did in 2023, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 42 | $1,040 |
| 2023 | 42 | 1 | 17 | $1,040 |
Drugs they prescribed that Part D paid
$83,464
Pharmacies billed $83,464 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (18 of 1,131) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
1,021 generic and 99 brand-name prescriptions · $83,464 in drug cost · 11 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Losartan | 79 | $1,132 | $14 |
| Atorvastatin | 97 | $917 | $9 |
| Levothyroxine | 56 | $678 | $12 |
| Amlodipine Besylate | 69 | $571 | $8 |
| Albuterol Sulfate Hfa | 15 | $507 | $34 |
See all 27 drugs
| Losartan | 79 | $1,132 | $14 |
| Atorvastatin | 97 | $917 | $9 |
| Levothyroxine | 56 | $678 | $12 |
| Amlodipine Besylate | 69 | $571 | $8 |
| Albuterol Sulfate Hfa | 15 | $507 | $34 |
| Duloxetine | 23 | $485 | $21 |
| Rosuvastatin | 34 | $455 | $13 |
| Omeprazole | 21 | $451 | $21 |
| Escitalopram | 17 | $433 | $25 |
| Tamsulosin | 22 | $432 | $20 |
| Metformin | 36 | $362 | $10 |
| Metoprolol | 22 | $360 | $16 |
| Sertraline | 40 | $308 | $8 |
| Estradiol | 13 | $307 | $24 |
| Simvastatin | 27 | $299 | $11 |
| Pravastatin | 16 | $299 | $19 |
| Gabapentin | 15 | $232 | $15 |
| Mirtazapine | 16 | $224 | $14 |
| Metformin Hcl Er | 18 | $223 | $12 |
| Lisinopril | 22 | $173 | $8 |
| Hydrochlorothiazide | 13 | $156 | $12 |
| Glipizide Er | 11 | $124 | $11 |
| Atenolol | 19 | $123 | $6 |
| Alendronate | 21 | $115 | $5 |
| Promethazine | 12 | $97 | $8 |
| Trazodone | 14 | $95 | $7 |
| Citalopram Hbr | 11 | $58 | $5 |
Year by year
| 2024 | 1,131 | 170 | 2% (18) | 9% | $83,464 |
| 2023 | 1,690 | 235 | 3% (42) | 8% | $118,026 |
| 2022 | 753 | 164 | 4% (32) | None | $42,853 |
| 2020 | 21 | 11 | None | None | $34,764 |
| 2019 | 42 | 21 | 0% (0) | None | $47,259 |
| 2018 | 121 | 22 | 0% (0) | None | $9,002 |
| 2017 | 23 | 11 | 0% (0) | None | $2,488 |
| 2016 | 18 | None | 0% (0) | None | $917 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 37 drugs
| Eliquis | 14 | $19,178 | $1,370 |
| Atorvastatin | 146 | $3,473 | $24 |
| Rosuvastatin | 53 | $1,823 | $34 |
| Duloxetine | 41 | $1,457 | $36 |
| Amlodipine Besylate | 112 | $1,356 | $12 |
| Losartan | 97 | $1,291 | $13 |
| Levothyroxine | 57 | $912 | $16 |
| Hydrocodone-Acetaminophen | 16 | $885 | $55 |
| Mirtazapine | 24 | $861 | $36 |
| Metoprolol | 43 | $791 | $18 |
| Omeprazole | 39 | $704 | $18 |
| Tamsulosin | 35 | $690 | $20 |
| Albuterol Sulfate Hfa | 19 | $581 | $31 |
| Gabapentin | 38 | $545 | $14 |
| Finasteride | 14 | $503 | $36 |
| Sertraline | 47 | $466 | $10 |
| Fluticasone Propionate | 31 | $420 | $14 |
| Metformin | 33 | $413 | $13 |
| Escitalopram | 15 | $394 | $26 |
| Metformin Hcl Er | 20 | $377 | $19 |
| Pravastatin | 20 | $375 | $19 |
| Simvastatin | 37 | $372 | $10 |
| Lisinopril | 26 | $332 | $13 |
| Donepezil | 16 | $279 | $17 |
| Diclofenac | 12 | $268 | $22 |
| Allopurinol | 14 | $232 | $17 |
| Estradiol | 11 | $206 | $19 |
| Spironolactone | 16 | $187 | $12 |
| Alendronate | 19 | $184 | $10 |
| Hydromorphone | 11 | $183 | $17 |
| Carvedilol | 19 | $149 | $8 |
| Clopidogrel | 12 | $141 | $12 |
| Atenolol | 22 | $136 | $6 |
| Zolpidem | 14 | $110 | $8 |
| Citalopram Hbr | 11 | $98 | $9 |
| Hydrochlorothiazide | 25 | $85 | $3 |
| Alprazolam | 11 | $78 | $7 |
2022: 16 drugs
| Eliquis | 17 | $10,186 | $599 |
| Atorvastatin | 60 | $793 | $13 |
| Rosuvastatin | 33 | $703 | $21 |
| Duloxetine | 14 | $685 | $49 |
| Omeprazole | 18 | $409 | $23 |
| Losartan | 48 | $396 | $8 |
| Levothyroxine | 18 | $335 | $19 |
| Gabapentin | 27 | $288 | $11 |
| Amlodipine Besylate | 38 | $279 | $7 |
| Mirtazapine | 13 | $272 | $21 |
| Metoprolol | 19 | $188 | $10 |
| Metformin Hcl Er | 13 | $162 | $12 |
| Metformin | 14 | $112 | $8 |
| Alendronate | 12 | $86 | $7 |
| Alprazolam | 11 | $59 | $5 |
| Hydrochlorothiazide | 19 | $27 | $1 |
2018: 1 drug
| Atorvastatin | 15 | $239 | $16 |
Money from drug and device companies
$30 in 2025
A payment is not proof that care is biased.
| Heartflow | Ffrct | $30 | 1 payment
|
See the published payment
| Heartflow | Meals · 2025-10-27 | Ffrct | $30 |
Professional record
- NPI
- 1245625490
- Licence
- CA A146955California A146955: Current · expires 2027-01-31
- Trained
- Harvard Medical School, 2015
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 207RH0000X (207RH0000X); Medical oncology (207RX0202X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2015-04-04
- NPI last updated
- 2024-04-24
- NPI record certified
- 2024-04-24
This is when the NPI record was last certified, not a medical board exam.